<?xml version="1.0" encoding="UTF-8"?>
<ref id="B27-molecules-25-05243">
 <label>27.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Wagner</surname>
    <given-names>C.E.</given-names>
   </name>
   <name>
    <surname>Jurutka</surname>
    <given-names>P.W.</given-names>
   </name>
   <name>
    <surname>Marshall</surname>
    <given-names>P.A.</given-names>
   </name>
   <name>
    <surname>Groy</surname>
    <given-names>T.L.</given-names>
   </name>
   <name>
    <surname>Van Der Vaart</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Ziller</surname>
    <given-names>J.W.</given-names>
   </name>
   <name>
    <surname>Furmick</surname>
    <given-names>J.K.</given-names>
   </name>
   <name>
    <surname>Graeber</surname>
    <given-names>M.E.</given-names>
   </name>
   <name>
    <surname>Matro</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Miguel</surname>
    <given-names>B.V.</given-names>
   </name>
  </person-group>
  <article-title>Modeling, synthesis and biological evaluation of potential retinoid X receptor (RXR) selective agonists: Novel analogues of 4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl) ethynyl] benzoic acid (bexarotene)</article-title>
  <source>J. Med. Chem.</source>
  <year>2009</year>
  <volume>52</volume>
  <fpage>5950</fpage>
  <lpage>5966</lpage>
  <pub-id pub-id-type="doi">10.1021/jm900496b</pub-id>
  <pub-id pub-id-type="pmid">19791803</pub-id>
 </element-citation>
</ref>
